28747658|t|A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.
28747658|a|Recent data highlight the presence, in HIV-1-seropositive patients with lymphoma, of p17 variants (vp17s) endowed with B-cell clonogenicity, suggesting a role of vp17s in lymphomagenesis. We investigated the mechanisms responsible for the functional disparity on B cells between a wild-type p17 (refp17) and a vp17 named S75X. Here, we show that a single Arginine (R) to Glycine (G) mutation at position 76 in the refp17 backbone (p17R76G), as in the S75X variant, is per se sufficient to confer a B-cell clonogenic potential to the viral protein and modulate, through activation of the PTEN/PI3K/Akt signaling pathway, different molecules involved in apoptosis inhibition (CASP-9, CASP-7, DFF-45, NPM, YWHAZ, Src, PAX2, MAPK8), cell cycle promotion and cancer progression (CDK1, CDK2, CDK8, CHEK1, CHEK2, GSK-3 beta, NPM, PAK1, PP2C-alpha). Moreover, the only R to G mutation at position 76 was found to strongly impact on protein folding and oligomerization by altering the hydrogen bond network. This generates a conformational shift in the p17 R76G mutant which enables a functional epitope(s), masked in refp17, to elicit B-cell growth-promoting signals after its interaction with a still unknown receptor(s). Our findings offer new opportunities to understand the molecular mechanisms accounting for the B-cell growth-promoting activity of vp17s.
28747658	75	80	HIV-1	OrganismTaxon	11676
28747658	96	99	p17	GeneOrGeneProduct	155348
28747658	140	158	HIV-1-seropositive	DiseaseOrPhenotypicFeature	D006679
28747658	159	167	patients	OrganismTaxon	9606
28747658	173	181	lymphoma	DiseaseOrPhenotypicFeature	D008223
28747658	186	189	p17	GeneOrGeneProduct	155348
28747658	272	287	lymphomagenesis	DiseaseOrPhenotypicFeature	D008223
28747658	392	395	p17	GeneOrGeneProduct	155348
28747658	422	426	S75X	SequenceVariant	p|SUB|S|75|X
28747658	456	507	Arginine (R) to Glycine (G) mutation at position 76	SequenceVariant	p|SUB|R|76|G
28747658	532	535	p17	GeneOrGeneProduct	155348
28747658	535	539	R76G	SequenceVariant	p|SUB|R|76|G
28747658	552	556	S75X	SequenceVariant	p|SUB|S|75|X
28747658	688	692	PTEN	GeneOrGeneProduct	5728
28747658	693	697	PI3K	GeneOrGeneProduct	5291
28747658	698	701	Akt	GeneOrGeneProduct	207
28747658	775	781	CASP-9	GeneOrGeneProduct	842
28747658	783	789	CASP-7	GeneOrGeneProduct	840
28747658	791	797	DFF-45	GeneOrGeneProduct	1676
28747658	799	802	NPM	GeneOrGeneProduct	4869
28747658	804	809	YWHAZ	GeneOrGeneProduct	7534
28747658	811	814	Src	GeneOrGeneProduct	6714
28747658	816	820	PAX2	GeneOrGeneProduct	5076
28747658	822	827	MAPK8	GeneOrGeneProduct	5599
28747658	855	861	cancer	DiseaseOrPhenotypicFeature	D009369
28747658	875	879	CDK1	GeneOrGeneProduct	983
28747658	881	885	CDK2	GeneOrGeneProduct	1017
28747658	887	891	CDK8	GeneOrGeneProduct	1024
28747658	893	898	CHEK1	GeneOrGeneProduct	1111
28747658	900	905	CHEK2	GeneOrGeneProduct	11200
28747658	907	917	GSK-3 beta	GeneOrGeneProduct	2932
28747658	919	922	NPM	GeneOrGeneProduct	4869
28747658	924	928	PAK1	GeneOrGeneProduct	5058
28747658	930	940	PP2C-alpha	GeneOrGeneProduct	5494
28747658	962	992	R to G mutation at position 76	SequenceVariant	p|SUB|R|76|G
28747658	1145	1148	p17	GeneOrGeneProduct	155348
28747658	1149	1153	R76G	SequenceVariant	p|SUB|R|76|G
28747658	Association	p|SUB|S|75|X	D009369	No
28747658	Association	p|SUB|R|76|G	D009369	Novel
28747658	Association	D009369	5494	No
28747658	Association	D009369	5058	No
28747658	Association	D009369	2932	No
28747658	Association	D009369	11200	No
28747658	Association	D009369	1111	No
28747658	Association	D009369	1024	No
28747658	Association	D009369	1017	No
28747658	Association	D009369	983	No
28747658	Association	D009369	4869	No
28747658	Association	155348	D008223	Novel
28747658	Association	155348	5494	Novel
28747658	Association	155348	5058	Novel
28747658	Association	155348	2932	Novel
28747658	Association	155348	11200	Novel
28747658	Association	155348	1111	Novel
28747658	Association	155348	1024	Novel
28747658	Association	155348	1017	Novel
28747658	Association	155348	983	Novel
28747658	Association	155348	D009369	No
28747658	Association	155348	5599	Novel
28747658	Association	155348	5076	Novel
28747658	Association	155348	6714	Novel
28747658	Association	155348	7534	Novel
28747658	Association	155348	4869	Novel
28747658	Association	155348	1676	Novel
28747658	Association	155348	840	Novel
28747658	Association	155348	842	Novel